Young age - an unusual finding of Hürthle cell carcinoma
Abstract
Keywords
Full Text:
PDFReferences
Ahmadi S, Stang M, Jiang X, Sosa JA. Hürthle cell carcinoma: current perspectives. Onco Targets Ther 2016; (9):6873-6884.
Donatini G, Beaulieu A, Castagnet M, Kraimps JL, Levillain P, Fromont G. Thyroid Hürthle cell tumors: research of potential markers of malignancy. J Endocrinol Invest 2016; 39(2):153-158.
Oluic B, Paunovic I, Loncar Z, et al. Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hürthle cell carcinoma: a single center experience. BMC Cancer 2017; 17(1):371.
Li P, Liu P, Zhang H. Ultrasonic diagnosis for thyroid Hürthle cell tumor. Cancer Biomark 2017; 20(3):235-240.
Jillard CL, Youngwirth L, Scheri RP, Roman S, Sosa JA. Radioactive iodine treatment is associated with improved survival for patients with Hürthle cell carcinoma. Thyroid 2016; 26(7):959-964.
Xiong Y, Zhao Q, Li Z, et al. Propensity score matching analysis of the prognosis for the rare oxyphilic subtype of thyroid cancer (Hürthle cell carcinoma). Oncotarget 2017; 8(60):101362-101371.
Tai P, Korzeniowski M, Sadikov E, et al. Issues in managing Hürthle cell carcinoma of thyroid: a case report. Cureus 2017; 9(4):e1167.
DOI: http://dx.doi.org/10.22551/2018.21.0504.10144
Copyright (c) 2019 Laura Claudia Teodoriu, Delia Gabriela Ciobanu-Apostol, Alexandru Grigorovici, Cristina Preda
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ISSN: 2360-6975